Hyundai has always been up for a challenge. From the very beginning, the brand has punched above its weight, proudly carrying ...

At the time of writing, the ASX uranium share is down a whopping 25% to a 52-week low of 6.2 cents. Investors have been ...

Clinical data from the RESET-Myositis™ and RESET-SLE™ trials, along with initial clinical data from the RESET-SSc™ trial, to be presented this ...

A documentary chronicling the 100-year history of St. Mary’s General Hospital will be available online Friday. The 23-minute ...

BioSpace takes a look at the headlines across a heavy earnings week for biotechs, checking in on Allogene, Rapport and more.

Electric vehicles face unique challenges in cold climates, affecting their performance and practicality. Battery efficiency ...

FREDERICK, Md., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the "Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune ...

2019年9月2日，厦门大学附属第一医院厦门糖尿病研究所&西南科技大学生命科学与工程学院在Biomedicine & Pharmacotherapy (中科院二区 IF=6.9)期刊上在线发表题为 "Preconditioning with ...

The patient died four months after BEAM-101 infusion “due to respiratory failure that was determined by the investigator to ...

BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, ...

Descartes-08, Cartesian's lead mRNA cell therapy candidate, is an autologous mRNA-engineered chimeric antigen receptor T-cell therapy (mRNA CAR-T) product candidate targeting B-cell maturation antigen ...